Showing 20 of 94 recruiting trials for “esophageal-atresia”
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
RecruitingNCT05443841 ↗
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
RecruitingNCT06393140 ↗
The Study on the Mechanism of Radiotherapy-elicited Immune Response
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
👨⚕️ Jie He, MD, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Apr 2022View details ↗
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Mar 2022View details ↗
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
👨⚕️ Xiaolin GE, MM, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Jun 2021View details ↗
RecruitingNCT04911036 ↗
Study of the Effect of the Time of Diagnosis (Antenatal vs. Postnatal) on the Post-traumatic Reactions of Parents of Children Undergoing Oesophageal Atresia Surgery "
Fluorescence Image Guided Foregut Surgery
👨⚕️ Silvana PERRETTA, MD, PhD, Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg📍 1 site📅 Started Apr 2021View details ↗
RecruitingNCT07080437 ↗
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
RecruitingNCT04455282 ↗
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
👨⚕️ Nikolas Stoecklein, MD, Surgery, University Hospital Düsseldorf Germany📍 2 sites📅 Started Feb 2021View details ↗
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
👨⚕️ Peter Grimminger, MD,PhD, JGU Medizin Mainz, dept. AVTC📍 1 site📅 Started Jan 2021View details ↗
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
👨⚕️ Hanneke WM van Laarhoven, MD,PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Nov 2020View details ↗
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
RecruitingNCT04958720 ↗
Spanish Registry of Esophagogastric Cancer
👨⚕️ Paula Dr Jiménez Fonseca, MD-PhD, Sociedad Española de Oncología Medica (SEOM)📍 38 sites📅 Started Apr 2020View details ↗
Chemoradiotherapy in Unresectable Esophageal Cancer
👨⚕️ Xin Wang, MD, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College📍 5 sites📅 Started Oct 2019View details ↗
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
👨⚕️ Zhigang Li, MD, PhD, Shanghai Chest Hospital of Shanghai Jiao Tong University📍 6 sites📅 Started Sep 2019View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →